OTOFA 200 000 UI
rifamycine
Public price
26,60 MAD
Active substance
rifamycine
Laboratory
PROMOPHARM (HIKMA)
What is this medicine?
OTOFA 200 000 UI contains rifamycine. Its clinical use depends on the approved indication for this substance and the pharmaceutical form available in Morocco.
Verified summary
rifamycine, Solution auriculaire, 000 UI, Flacon de 10 ml
Common uses
Use is linked to the active substance, the selected indication, and the pharmaceutical form.
Class
Princeps
Laboratory
PROMOPHARM (HIKMA)
Hospital price
16,60 MAD
Strength
000 UI
Form
Solution auriculaire
Presentation
Flacon de 10 ml
ATC code
S02AA12
Type
Princeps
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2026-06-02: 26,60 MAD
